J. Stern & Co. LLP lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 18,504.6% during the 4th quarter, HoldingsChannel reports. The fund owned 2,127,248 shares of the medical equipment provider’s stock after acquiring an additional 2,115,814 shares during the period. Intuitive Surgical accounts for 0.4% of J. Stern & Co. LLP’s portfolio, making the stock its 25th largest position. J. Stern & Co. LLP’s holdings in Intuitive Surgical were worth $1,204,788,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Holos Integrated Wealth LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth about $25,000. Newbridge Financial Services Group Inc. lifted its holdings in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares during the period. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth about $28,000. Caitlin John LLC purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth about $30,000. Finally, Laurel Wealth Advisors LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth about $31,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the sale, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This trade represents a 46.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock valued at $3,059,135 over the last 90 days. 0.60% of the stock is owned by corporate insiders.
Intuitive Surgical Stock Up 0.1%
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter last year, the company earned $1.81 earnings per share. Intuitive Surgical’s revenue for the quarter was up 23.0% on a year-over-year basis. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.
Analyst Upgrades and Downgrades
ISRG has been the topic of several recent analyst reports. JPMorgan Chase & Co. cut their price objective on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. BTIG Research reiterated a “buy” rating and set a $574.00 price objective on shares of Intuitive Surgical in a report on Wednesday, April 22nd. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday. UBS Group dropped their target price on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Finally, Raymond James Financial dropped their target price on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $573.42.
Read Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Profile
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
